Despite the fact that prison and jail inmates have
disproportionately high rates of HIV infection compared to the
general public, this population too often has been neglected by
public health agencies.
No longer, says Anne Spaulding, MD, CCHP, team leader for the
corrections and substance abuse unit at the CDC’s National
Center for HIV, STD and TB Prevention.
"The CDC issued an important publication on HIV
screening and we made it in," she says. "What’s
exciting is that correctional facilities are acknowledged as key
sites for testing people who are at risk for HIV."
The document, Revised Guidelines for HIV Counseling, Testing,
and Referral, was issued last November along with a companion
document titled Revised Recommendations for HIV Screening of
Pregnant Women.
"These guidelines acknowledge that HIV prevalence is
high in these areas, greater than 1%, and generally in sites
where the prevalence is so high we recommend that all people
should be approached, not just those who self-identify as high
risk," explains Spaulding, who joined the CDC in November
after six years of work in correctional medicine. Board
certified in both internal medicine and infectious disease,
Spaulding also is the new president of the Society of
Correctional Physicians (www.corrdocs.org).
Just as important as the mention of
corrections, Spaulding notes, is the guidelines’ emphasis on
voluntary, informed, consent-based testing. The document
addressing pregnant women, while it does not discuss
correctional settings, provides good detail about how to do
this.
"We should take the message of those recommendations and
apply them in the same spirit when we approach men and women in
correctional facilities," Spaulding says.
Major Revisions
In the guidelines for screening of pregnant women, the CDC
summarizes the major revisions from the previous set, issued in
1995. These include recommendations to . . .
1. Emphasize HIV testing as a
routine part of prenatal care and strengthen the recommendation
that all pregnant women be tested.
2. Simplify the testing process so
that pretest counseling is not a barrier to testing.
3. Make the consent process more
flexible to allow for various types of informed consent.
4. Explore and address reasons for
refusal to test.
5. Emphasize HIV testing and
treatment at the time of labor and delivery for women who have
not received prenatal testing and antiretroviral drugs.
Acknowledging that correctional settings present unique
challenges and, frequently, limited resources, Spaulding says
that, "if it is at all feasible," testing should be
offered as a routine component of medical encounters.
"Everyone needs to know their HIV status but especially
pregnant women. It would be extremely misfortunate for a woman
to receive health services while incarcerated and leave the
facility not knowing she has HIV. The new guidelines drive home
the point that testing can save the life of her baby."
Middle Ground
Elaborating on the notion of routine testing, Spaulding says
it occupies a middle ground between voluntary and mandatory.
"If we routinely give every inmate the opportunity to
undergo testing, they’d still be able to opt out now and then
be tested voluntarily later. But then we need to remove barriers
to voluntary testing, as when, for example, somebody has to
request a test in writing or come forward in a group."
Instead, she suggests, the offer to test can be routinized by
making the test available during other health care
interventions, such as whenever an inmate receives a tuberculin
skin test or syphilis serologies.
Offering the test is just part of the solution, though, she
cautions. Inmates must receive HIV counseling, and those who are
tested must give explicit consent. Again, though, these steps
must be simplified to prevent unnecessary barriers.
Both sets of guidelines are posted on the Web at www.cdc.gov/hiv/
pubs/guidelines.htm.
To contact Spaulding, send an e-mail to aws6@cdc.gov.
Spaulding advises that she cannot answer specific questions
about patient care, but welcomes correspondence concerning
prevention of HIV and other infectious diseases among
incarcerated people.